Ascendia

 

  MARKET NEWS

Conduit Pharmaceuticals Enters Joint Development Agreement With Manoira
HCW Biologics Completes Deliverable & Solidifies License Agreement With WY Biotech
Elicio Therapeutics Secures $10 Million in Financing
Trethera Secures New License, Strengthening TRE-515 Intellectual Property Portfolio & Extending Market Exclusivity to 2045
Rilzabrutinib Granted Orphan Drug Designation in the US for Sickle Cell Disease
Medicines Discovery Catapult & the Francis Crick Institute Partner to Support KQ Labs, a Leading Accelerator for Life Sciences Innovators
Symeres & Yoneda Labs Use AI to Optimize Cross-Coupling Reactions
Coya Therapeutics Announces Issuance of New Patent Protecting Methods of Producing Recombinant Human Interleukin-2 Liquid Formulations
Fujifilm Rebrands Life Sciences Companies to Strengthen Position as Strategic Partners for Life, Offering End-to-End Solutions
Kymera Therapeutics Announces Positive First-in-Human Results From Phase 1 Trial of a First-in-Class, Oral STAT6 Degrader

  EXPERT CONTENT & RESOURCES

Exploring New Potential Through 505(b)(2)

Exploring New Potential Through 505(b)(2)

When filing for a drug product approval via the 505(b)(2) regulatory pathway rather than a traditional development pathway, companies are afforded several advantages.

Ionizable Lipids in LNPs: A Selection Guide

Ionizable Lipids in LNPs: A Selection Guide

Finding the right ionizable lipid is critical for optimal formulations. This guide helps navigate the wide range of ionizable lipids for specific therapeutic needs. Explore lipids by target or cargo type.

Understanding the Foundation of LNP Formulation Success

Understanding the Foundation of LNP Formulation Success

Download our eBook and discover everything you need to know about lipids for developing LNP therapies, including:….

  FEATURED EDITORIAL

  COMPANY PROFILE

Sharp is a leading global provider of commercial packaging, clinical supply services and sterile manufacturing solutions for the pharmaceutical and biotechnology industries. For over 70 years, we have partnered with clients across every phase of the drug development journey — from early-phase clinical trials through to commercial launch and lifecycle management. Our mission is to support our clients in delivering life-changing therapies safely, efficiently and compliantly to patients worldwide. Click here for more.

  WHITEPAPERS & WEBINARS

WEBINAR ON DEMAND: Precision at Scale: Enabling Novel Therapeutics With Nanoparticle Manufacturing

WEBINAR ON DEMAND: Precision at Scale: Enabling Novel Therapeutics With Nanoparticle Manufacturing

Watch this on-demand webinar to learn about the key steps and considerations in bringing novel nanoparticle-based therapeutics from early R&D to commercial stages. Drawing from our 20 years of experience in the CDMO space, we cover critical topics unique to nanomaterials…..

ON-DEMAND WEBINAR - CMC Strategy to Take Bispecifics From DNA to IND in 13 Months* by Lonza

ON-DEMAND WEBINAR - CMC Strategy to Take Bispecifics From DNA to IND in 13 Months* by Lonza

Lonza has applied it’s 35 years of CMC experience in Biologics to develop an end-to-end comprehensive DS/DP DNA to IND strategy in 13 months. This presentation….

  WHITEPAPERS & WEBINARS

WHITEPAPER - Container Selection for a Highly Sensitive Drug Product: A Success Story

WHITEPAPER - Container Selection for a Highly Sensitive Drug Product: A Success Story

Our client, a leading pharmaceutical company, came to us for a solution to a very specific problem. They needed a staked needle prefilled syringe (PFS) in a disposable auto-injector for their high-concentration monoclonal antibody product. These products are among the …

WHITEPAPER: Partnering With Gattefossé to Tackle Veterinary Medicine Challenges

WHITEPAPER: Partnering With Gattefossé to Tackle Veterinary Medicine Challenges

Veterinary medicines face unique challenges due to species diversity, physiology, and dosing needs. Animals can’t be instructed to take medicine, so palatability, safety, and bioavailability are key.

Gattefossé focuses on customers, veterinarians, pet owners, and animals themselves to help them …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

June 11 – Inhalation Delivery
June 18 – Bioavailability